| NANOVIRICIDES NEW DL-,01 |
| USA |
| Gesundheit |
| US6300873022 / A2PSNF |
| NV3P (Frankfurt) |
| FRA:NV3P, ETR:NV3P, NV3P:GR |
| - |
| https://www.nanoviricides.. |
|
Nanoviricides Inc. is a pioneering biotechnology company that focuses on the development of therapeutics to combat viral infections using nanotechnology. The company is dedicated to creating antiviral nanomedicine known as "nanoviricides," which are ..
>Volltext.. |
| 30.6 Mio. EUR |
| 27.81 Mio. EUR |
| - |
| -6.57 Mio. EUR |
| -6.97 Mio. EUR |
| -0.38 EUR |
| - |
| 2.77 Mio. EUR |
| - |
| 3.02 |
| - |
| 22.11% |
| - |
| - |
| - |
| - |
| NANOVIRICIDES |
| 26.05.26 |
|